MYGN icon

Myriad Genetics
MYGN

Overview Fund Activity

205 hedge funds and large institutions have $1.98B invested in Myriad Genetics in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 65 increasing their positions, 74 reducing their positions, and 22 closing their positions.

Holders
205
Holders Change
+8
Holders Change %
+4.06%
% of All Funds
3.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
65
Reduced
74
Closed
22
Calls
$7.18M
Puts
$811K
Net Calls
+$6.37M
Net Calls Change
-$1.84M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$128M
2
CCM
2
Camber Capital Management
Massachusetts
$88.2M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$8.09M
4
Bank of America
4
Bank of America
North Carolina
$69.5M
5
Artisan Partners
5
Artisan Partners
Wisconsin
$58.6M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$8.69M
2
Goldman Sachs
2
Goldman Sachs
New York
$39.6M
3
State Street
3
State Street
Massachusetts
$106M
4
Nuveen Asset Management
4
Nuveen Asset Management
Illinois
$11M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$226M
Name Market Value Shares Shares
Change 		Shares
Change %
SIC
226
SJS Investment Consulting
Ohio
$0 1 +1 New
SC
227
Schubert & Co
Texas
$0 10 +5 +100%
CI
228
Cordant Inc
Oregon
$0 5 +5 New
DI
229
Disciplined Investments
Oklahoma
$0 6 +6 New
AF
230
Allworth Financial
California
$0 9 +9 New
JWA
231
JFS Wealth Advisors
Pennsylvania
$0 18 +12 +200%
6 7 8 9
10